Two variants of the major serine protease inhibitor from the sea anemone Stichodactyla helianthus, expressed in Pichia pastoris-Reference-Cited by-同舟云学术

Two variants of the major serine protease inhibitor from the sea anemone Stichodactyla helianthus, expressed in Pichia pastoris

Published:2016-07 Issue: Volume:123 Page:42-50
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

García-Fernández Rossana,Ziegelmüller Patrick,González Lidice,Mansur Manuel,Machado Yoan,Redecke Lars,Hahn Ulrich,Betzel Christian,Chávez María de los Ángeles

Funder

International Foundation for Science

German Federal Ministry of Education and Research

German Academic Exchange Service

Publisher

Elsevier BV

Subject

Biotechnology

Reference60 articles.

1. Structure-function relationships in serine protease-bovine pancreatic trypsin inhibitor interaction;Krowarsch;Protein Peptide Lett.,2005

2. Inhibition of human leukocyte and porcine pancreatic elastase by homologues of bovine pancreatic trypsin inhibitor;Kraunsoe;Biochemistry,1996

3. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases;Krowarsch;J. Mol. Biol.,1999

4. The P(2)′ residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity;Salameh;Biochem. J.,2011

5. Canonical protein inhibitors of serine proteases;Krowarsch;Cell Mol. Life Sci. CMLS,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diversity analysis of sea anemone peptide toxins in different tissues of Heteractis crispa based on transcriptomics;Scientific Reports;2024-04-01

2. Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery;Antiviral Drugs - Intervention Strategies;2022-10-05

3. Ayurvedic Medicinal Plants Against COVID-19: An In Silico Analysis;Natural Product Communications;2021-11

4. Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach;Biomedicine & Pharmacotherapy;2021-08

5. Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data;EUR REV MED PHARMACO;2021